before few years, the UK has witnessed a revolution in clinical bodyweight‑loss remedies — in the introduction of semaglutide (Wegovy®) into the expanding reputation of tirzepatide (Mounjaro®). Now, An additional name is drawing focus in both scientific and general public wellbeing circles: Retat